tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Revelation Biosciences Inc

REVB
Add to Watchlist
0.988USD
-0.007-0.71%
Close 07-31 16:00（ET）Quotes delayed by 15 min
391.32KMarket Cap
LossP/E TTM

Revelation Biosciences Inc

0.988
-0.007-0.71%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

REVB Financials

See Revelation Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Revelation Biosciences Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-2.71/-1.15
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-95.78
90.90%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Financial Indicators
EPS
57.23%-2.71
89.01%-1.64
82.38%-7.07
91.46%-21.03
94.64%-6.33
96.78%-14.89
93.32%-40.15
31.36%-246.27
-102.94%-118.10
80.97%-462.47
---601.03
---358.79
--4.01K
---2.43K
---9.62K
----
----
----
----
----
----
Net Profit
-323.71%-8.69M
-45.50%-2.51M
-108.65%-4.68M
32.94%-5.63M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
----
---2.61M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
Income Statement
Operating profit
-47.61%-3.09M
-46.62%-2.57M
-8.14%-1.94M
2.42%-2.46M
-10.14%-2.09M
24.59%-1.75M
35.32%-1.80M
-30.49%-2.52M
-17.43%-1.90M
-90.91%-2.33M
-131.59%-2.78M
-3.90%-1.93M
75.41%-1.62M
68.41%-1.22M
60.60%-1.20M
---1.86M
-152.57%-6.59M
-136.72%-3.86M
-313.37%-3.04M
----
---2.61M
Net Profit
-323.71%-8.69M
-45.50%-2.51M
-108.65%-4.68M
32.94%-5.63M
23.51%-2.05M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
-82.42%-2.20M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
68.72%-1.21M
61.55%-1.17M
---1.83M
-153.28%-6.62M
-136.95%-3.86M
-313.45%-3.04M
----
---2.61M
Balance Sheet
Current assets
261.67%14.21M
64.67%10.81M
92.71%12.83M
-56.06%5.36M
-73.14%3.93M
-45.95%6.57M
-52.93%6.66M
-23.57%12.20M
-18.92%14.62M
124.40%12.15M
117.48%14.15M
293.98%15.96M
129.13%18.04M
183.11%5.41M
14.08%6.51M
-49.71%4.05M
--7.87M
--1.91M
--5.70M
--8.06M
----
Total current liabilities
30.07%1.42M
4.42%2.00M
-54.40%1.85M
-85.90%1.57M
-79.16%1.09M
-65.61%1.91M
-24.69%4.07M
140.68%11.13M
-35.46%5.23M
25.03%5.56M
23.46%5.40M
-22.89%4.62M
0.28%8.10M
107.83%4.45M
97.52%4.37M
257.82%6.00M
--8.08M
--2.14M
--2.21M
--1.68M
----
Total assets
278.92%15.04M
74.91%11.58M
90.74%12.86M
-56.03%5.40M
-72.99%3.97M
-45.78%6.62M
-52.60%6.74M
-23.50%12.27M
-18.86%14.70M
121.91%12.21M
115.38%14.22M
286.11%16.04M
127.06%18.12M
169.48%5.50M
12.47%6.60M
-49.61%4.15M
--7.98M
--2.04M
--5.87M
--8.24M
----
Total liabilities
88.65%2.06M
42.24%2.72M
-54.40%1.85M
-85.90%1.57M
-79.16%1.09M
-65.61%1.91M
-24.69%4.07M
140.68%11.13M
-35.46%5.23M
25.03%5.56M
23.46%5.40M
-22.89%4.62M
0.28%8.10M
107.83%4.45M
97.52%4.37M
257.82%6.00M
--8.08M
--2.14M
--2.21M
--1.68M
----
Total equity
350.89%12.99M
88.20%8.86M
311.50%11.00M
235.47%3.83M
-69.59%2.88M
-29.17%4.71M
-69.68%2.67M
-90.01%1.14M
-5.44%9.47M
531.64%6.65M
295.86%8.82M
719.36%11.41M
10269.06%10.02M
1158.06%1.05M
-39.05%2.23M
-128.06%-1.84M
---98.51K
---99.47K
--3.66M
--6.57M
----
Cash Flow Statement
Net operating income
-15.05%-3.21M
47.51%-1.97M
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
-111.39%-2.00M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
67.09%-947.47K
22.52%-1.73M
---3.71M
-102.77%-4.83M
-321.78%-2.88M
-267.82%-2.23M
----
---2.38M
Net investment
---71.88K
-100.00%0.00
100.00%0.00
--0.00
100.00%0.00
--17.69K
---17.69K
--0.00
---19.17K
----
----
----
----
-100.00%0.00
--0.00
--0.00
100.00%0.00
--16.15K
--0.00
----
---99.10K
Net financing
--6.70M
-101.12%-41.17K
143.77%9.12M
--3.39M
-100.00%0.00
--3.69M
--3.74M
-100.00%0.00
-61.37%5.42M
-100.00%0.00
-100.00%0.00
--15.00
30.57%14.02M
--5.00K
--4.45M
--0.00
34.19%10.74M
-100.00%0.00
--0.00
----
--8.00M

FAQs

What are the current assets of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its current assets were 10.81M, with a year-on-year change of 64.67.

What are the total assets of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its total assets of Revelation Biosciences Inc were 11.58M, with a year-on-year change of 74.91.

What are the total liabilities of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its total liabilities of Revelation Biosciences Inc were 2.72M, with a year-on-year change of 42.24.

What is the total equity of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its total equity of Revelation Biosciences Inc was 8.86M, with a year-on-year change of 88.20.

What is the net operating income of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its net operating income of Revelation Biosciences Inc was -7.35M, with a year-on-year change of 7.90.

What is the net financing of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its net financing of Revelation Biosciences Inc was 12.47M, with a year-on-year change of -2.93.

What is the Earnings Per Share (EPS) of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -95.78, with a year-on-year change of 90.90.

What is the net income of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its net income was -14.87M, with a year-on-year change of 1.15.

What is the Return on Equity (ROE) of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -219.10, with a year-on-year change of 17.28.

What is the Return on Assets (ROA) of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -97.93, with a year-on-year change of 38.68.

What is the operating profit of Revelation Biosciences Inc?

According to Revelation Biosciences Inc's FY2025 earnings report, its operating profit was -7.35M, with a year-on-year change of 7.90.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy